DHG Pharmaceutical JSC (HOSE:DHG)

Vietnam flag Vietnam · Delayed Price · Currency is VND
102,800
+1,300 (1.28%)
At close: Aug 5, 2025
1.28%
Market Cap13.44T
Revenue (ttm)4.90T
Net Income (ttm)839.32B
Shares Out130.75M
EPS (ttm)6,419.00
PE Ratio16.01
Forward PE15.46
Dividend10,000.00 (9.73%)
Ex-Dividend DateMay 23, 2025
Volume25,034
Average Volume19,428
Open101,500
Previous Close101,500
Day's Range101,000 - 103,000
52-Week Range87,000 - 114,000
Beta0.41
RSI58.18
Earnings DateJul 18, 2025

About Aspen Technology

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in dietary supplements and pharmaceuticals cosmetics. The company exports its products to approximately 20 countries. The company was founded... [Read more]

Industry Pharmaceutical Preparations
Founded 1974
Employees 2,806
Stock Exchange Ho Chi Minh Stock Exchange
Ticker Symbol DHG
Full Company Profile

Financial Performance

In 2024, DHG Pharmaceutical JSC's revenue was 4.88 trillion, a decrease of -2.60% compared to the previous year's 5.02 trillion. Earnings were 753.55 billion, a decrease of -25.91%.

Financial Statements

News

There is no news available yet.